Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Legend Biotech Corp ADR (NASDAQ: LEGN) closed at $31.52 down -7.10% from its previous closing price of $33.93. In other words, the price has decreased by -$7.10 from its previous closing price. On the day, 2.2 million shares were traded. LEGN stock price reached its highest trading level at $34.84 during the session, while it also had its lowest trading level at $31.39.
Ratios:
For a deeper understanding of Legend Biotech Corp ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.54 and its Current Ratio is at 4.62. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on October 08, 2024, initiated with a Buy rating and assigned the stock a target price of $86.
On June 17, 2024, Truist started tracking the stock assigning a Buy rating and target price of $88.
H.C. Wainwright reiterated its Buy rating for the stock on May 24, 2024, while the target price for the stock was revised from $86 to $73.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 25 ’25 when Yeung Jessie bought 339 shares for $35.28 per share.
Huang Ying bought 4,064 shares of LEGN for $143,371 on Mar 25 ’25. On Mar 25 ’25, another insider, Sanders Corazon (Corsee) D., who serves as the Director of the company, bought 307 shares for $36.33 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LEGN now has a Market Capitalization of 5788616192 and an Enterprise Value of 10805163008. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.23 while its Price-to-Book (P/B) ratio in mrq is 5.56. Its current Enterprise Value per Revenue stands at 17.226 whereas that against EBITDA is -36.716.
Stock Price History:
The Beta on a monthly basis for LEGN is 0.21, which has changed by -0.4409365 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, LEGN has reached a high of $60.87, while it has fallen to a 52-week low of $30.17. The 50-Day Moving Average of the stock is -13.33%, while the 200-Day Moving Average is calculated to be -27.67%.
Shares Statistics:
For the past three months, LEGN has traded an average of 1.22M shares per day and 1067550 over the past ten days. A total of 183.65M shares are outstanding, with a floating share count of 181.14M. Insiders hold about 1.37% of the company’s shares, while institutions hold 53.55% stake in the company. Shares short for LEGN as of 1741910400 were 11387847 with a Short Ratio of 9.36, compared to 1739491200 on 13344457. Therefore, it implies a Short% of Shares Outstanding of 11387847 and a Short% of Float of 11.91.
